# Nicotinic Receptor Genetic Variation and Alcohol Reward

> **NCT03294460** · PHASE1 · RECRUITING · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 128 (estimated)

## Conditions studied

- Alcohol Drinking

## Interventions

- **DRUG:** Alcohol (Oral)
- **DRUG:** Alcohol (IV)
- **DRUG:** Alcohol (Ethanol)

## Key facts

- **NCT ID:** NCT03294460
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03294460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03294460, "Nicotinic Receptor Genetic Variation and Alcohol Reward". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03294460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*